Women’s Health Bulletin

Published by: Kowsar

Assessing the Effects of Antipsychotics on Parenting

Mary V. Seeman 1 , *
Author Information
1 Professor Emerita, Department of Psychiatry, University of Toronto, 260 Heath St. West Toronto, M5P 3L6, Ontario, Canada
Article information
  • Women’s Health Bulletin: January 2018, 5 (1); e13409
  • Published Online: December 9, 2017
  • Article Type: Review Article
  • Received: May 16, 2017
  • Accepted: July 8, 2017
  • DOI: 10.5812/whb.13409

To Cite: Seeman M V. Assessing the Effects of Antipsychotics on Parenting, Women Health Bull. 2018 ; 5(1):e13409. doi: 10.5812/whb.13409.

Copyright © 2017, Women’s Health Bulletin. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Findings
4. Conclusions
  • 1. Stambaugh LF, Forman-Hoffman V, Williams J, Pemberton MR, Ringeisen H, Hedden SL, et al. Prevalence of serious mental illness among parents in the United States: results from the National Survey of Drug Use and Health, 2008-2014. Ann Epidemiol. 2017; 27(3): 222-4[DOI][PubMed]
  • 2. Biebel K, Nicholson J, Woolsey K, Wolf T. Shifting an agency’s paradigm: Creating the capacity to intervene with parents with mental illness. Am J Psychiatr Rehabil. 2016; 19(4): 315-38[DOI]
  • 3. Guillemot J, Laborie C, Dutriez-Casteloot I, Maron M, Deloof S, Lesage J, et al. Could maternal perinatal atypical antipsychotic treatments program later metabolic diseases in the offspring? Eur J Pharmacol. 2011; 667(1-3): 13-6[DOI][PubMed]
  • 4. Oyebode F, Rastogi A, Berrisford G, Coccia F. Psychotropics in pregnancy: safety and other considerations. Pharmacol Ther. 2012; 135(1): 71-7[DOI][PubMed]
  • 5. Singh KP, Singh MK. In utero exposure to atypical antipsychotic drug, risperidone: Effects on fetal neurotoxicity in hippocampal region and cognitive impairment in rat offspring. Prog Neur Psychopharmacol Biol Psychiatr. 2017; 75: 35-44[DOI]
  • 6. Asnis GM. Tardive dyskinesia: is it or is it not? A review of the problems in diagnosis and a case study. Dis Nerv Syst. 1977; 38(10): 856-9[PubMed]
  • 7. Murphy R, Gallagher A, Sharma K, Ali T, Lewis E, Murray I, et al. Clozapine-induced stuttering: an estimate of prevalence in the west of Ireland. Ther Adv Psychopharmacol. 2015; 5(4): 232-6[DOI]
  • 8. Seeman MV. Sleepwalking, a possible side effect of antipsychotic medication. Psychiatr Q. 2011; 82(1): 59-67[DOI][PubMed]
  • 9. Tamanna S, Ullah MI, Pope CR, Holloman G, Koch CA. Quetiapine-induced sleep-related eating disorder-like behavior: a case series. J Med Case Rep. 2012; 6: 380[DOI][PubMed]
  • 10. Stip E, Lungu OV, Anselmo K, Letourneau G, Mendrek A, Stip B, et al. Neural changes associated with appetite information processing in schizophrenic patients after 16 weeks of olanzapine treatment. Transl Psychiatry. 2012; 2[DOI][PubMed]
  • 11. Leung M, Wrixon K, Remick RA. Olanzapine-induced hair loss. Can J Psychiatry. 2002; 47(9): 891-2[DOI][PubMed]
  • 12. Spencer DG, Lal H. Effects of anticholinergic drugs on learning and memory. Drug Dev Res. 1983; 3(6): 489-502[DOI]
  • 13. Hartz SM, Pato CN, Medeiros H, Cavazos-Rehg P, Sobell JL, Knowles JA, et al. Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry. 2014; 71(3): 248-54[DOI][PubMed]
  • 14. Seeman MV. Antipsychotic-induced somnolence in mothers with schizophrenia. Psychiatr Q. 2012; 83(1): 83-9[DOI][PubMed]
  • 15. Seeman MV. Intervention to prevent child custody loss in mothers with schizophrenia. Schizophr Res Treatment. 2012; 2012: 796763[DOI][PubMed]
  • 16. De Falco S, Emer A, Martini L, Rigo P, Pruner S, Venuti P. Predictors of mother-child interaction quality and child attachment security in at-risk families. Front Psychol. 2014; 5: 898[DOI][PubMed]
  • 17. Dolman C, Jones I, Howard LM. Pre-conception to parenting: a systematic review and meta-synthesis of the qualitative literature on motherhood for women with severe mental illness. Arch Womens Ment Health. 2013; 16(3): 173-96[DOI][PubMed]
  • 18. Miller DD. Atypical antipsychotics: sleep, sedation, and efficacy. Prim Care Companion J Clin Psychiatry. 2004; 6: 3-7[PubMed]
  • 19. Shirani A, Paradiso S, Dyken ME. The impact of atypical antipsychotic use on obstructive sleep apnea: a pilot study and literature review. Sleep Med. 2011; 12(6): 591-7[DOI][PubMed]
  • 20. Li M. Antipsychotic drugs on maternal behavior in rats. Behav Pharmacol. 2015; 26(6): 616-26[DOI][PubMed]
  • 21. Li M, Davidson P, Budin R, Kapur S, Fleming AS. Effects of typical and atypical antipsychotic drugs on maternal behavior in postpartum female rats. Schizophr Res. 2004; 70(1): 69-80[DOI][PubMed]
  • 22. Pereira M, Farrar AM, Hockemeyer J, Muller CE, Salamone JD, Morrell JI. Effect of the adenosine A2A receptor antagonist MSX-3 on motivational disruptions of maternal behavior induced by dopamine antagonism in the early postpartum rat. Psychopharmacology (Berl). 2011; 213(1): 69-79[DOI][PubMed]
  • 23. Wu R, Gao J, Chou S, Davis C, Li M. Behavioral, pharmacological and neuroanatomical analysis of serotonin 2C receptor agonism on maternal behavior in rats. Psychoneuroendocrinology. 2016; 73: 252-62[DOI][PubMed]
  • 24. van Baak MA. Influence of exercise on the pharmacokinetics of drugs. Clin Pharmacokinet. 1990; 19(1): 32-43[DOI][PubMed]
  • 25. Uchida H, Mamo DC, Mulsant BH, Pollock BG, Kapur S. Increased antipsychotic sensitivity in elderly patients: evidence and mechanisms. J Clin Psychiatry. 2009; 70(3): 397-405[PubMed]
  • 26. Davuluri S, Dharmarajan TS. Complementary and alternative medicine: Herbals and supplements: A review for the primary care physician. Cureus. 2014; [DOI]
  • 27. Desai HD, Seabolt J, Jann MW. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective. CNS Drugs. 2001; 15(6): 469-94[PubMed]
  • 28. Hagg S, Spigset O, Mjorndal T, Dahlqvist R. Effect of caffeine on clozapine pharmacokinetics in healthy volunteers. Br J Clin Pharmacol. 2000; 49(1): 59-63[PubMed]
  • 29. Kennedy WK, Jann MW, Kutscher EC. Clinically significant drug interactions with atypical antipsychotics. CNS Drugs. 2013; 27(12): 1021-48[DOI][PubMed]
  • 30. Lu ML, Lane HY. Clinically Significant Interactions with Antipsychotics. 2016; [DOI]
  • 31. Urichuk L, Prior TI, Dursun S, Baker G. Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions. Curr Drug Metab. 2008; 9(5): 410-8[PubMed]
  • 32. Gonzalez-Rodriguez A, Catalan R, Penades R, Ruiz Cortes V, Torra M, Seeman MV, et al. Antipsychotic Response Worsens With Postmenopausal Duration in Women With Schizophrenia. J Clin Psychopharmacol. 2016; 36(6): 580-7[DOI][PubMed]
  • 33. Li M. Antipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanisms. J Psychopharmacol. 2016; 30(8): 749-70[DOI][PubMed]
  • 34. Chouinard G, Chouinard VA. Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes. Psychother Psychosom. 2008; 77(2): 69-77[DOI][PubMed]
  • 35. Salomon C, Hamilton B, Elsom S. Experiencing antipsychotic discontinuation: results from a survey of Australian consumers. J Psychiatr Ment Health Nurs. 2014; 21(10): 917-23[DOI][PubMed]
  • 36. Cerovecki A, Musil R, Klimke A, Seemuller F, Haen E, Schennach R, et al. Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations. CNS Drugs. 2013; 27(7): 545-72[DOI][PubMed]
  • 37. Goudie AJ, Cole JC. Switching antipsychotics. Antipsychotic tolerance, withdrawal and relapse: unresolved issues and research implications. J Psychopharmacol. 2008; 22(7): 815-7[DOI][PubMed]
  • 38. Moncrieff J. Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse. Acta Psychiatr Scand. 2006; 114(1): 3-13[DOI][PubMed]
  • 39. Yin J, Barr AM, Ramos-Miguel A, Procyshyn RM. Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review. Curr Neuropharmacol. 2017; 15(1): 174-83[PubMed]
  • 40. Seeman MV, Seeman P. Is schizophrenia a dopamine supersensitivity psychotic reaction? Prog Neuropsychopharmacol Biol Psychiatry. 2014; 48: 155-60[DOI][PubMed]
  • 41. Remington G, Seeman P, Feingold A, Mann S, Shammi C, Kapur S. "Extended" antipsychotic dosing in the maintenance treatment of schizophrenia: a double-blind, placebo-controlled trial. J Clin Psychiatry. 2011; 72(8): 1042-8[DOI][PubMed]
  • 42. Seeman MV, Seeman N. The meaning of antipsychotic medication to patients with schizophrenia. J Psychiatr Pract. 2012; 18(5): 338-48[DOI][PubMed]
  • 43. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002; 63(10): 892-909[PubMed]
  • 44. Thorne S, Paterson B, Russell C, Schultz A. Complementary/alternative medicine in chronic illness as informed self-care decision making. Int J Nurs Stud. 2002; 39(7): 671-83[PubMed]
  • 45. Cobaugh DJ, Erdman AR, Booze LL, Scharman EJ, Christianson G, Manoguerra AS, et al. Atypical antipsychotic medication poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2007; 45(8): 918-42[DOI][PubMed]
  • 46. Love JN, Smith JA, Simmons R. Are one or two dangerous? Phenothiazine exposure in toddlers. J Emerg Med. 2006; 31(1): 53-9[DOI][PubMed]
  • 47. Hermans RC, Lichtwarck-Aschoff A, Bevelander KE, Herman CP, Larsen JK, Engels RC. Mimicry of food intake: the dynamic interplay between eating companions. PLoS One. 2012; 7(2)[DOI][PubMed]
  • 48. Sharps M, Higgs S, Blissett J, Nouwen A, Chechlacz M, Allen HA, et al. Examining evidence for behavioural mimicry of parental eating by adolescent females. An observational study. Appetite. 2015; 89: 56-61[DOI][PubMed]
  • 49. van Schaik JE, Hunnius S. Little chameleons: The development of social mimicry during early childhood. J Exp Child Psychol. 2016; 147: 71-81[DOI][PubMed]
  • 50. Shehnaz SI, Agarwal AK, Khan N. A systematic review of self-medication practices among adolescents. J Adolesc Health. 2014; 55(4): 467-83[DOI][PubMed]

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments